A detailed history of Rpo LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Rpo LLC holds 18,728 shares of ACIU stock, worth $50,191. This represents 0.07% of its overall portfolio holdings.

Number of Shares
18,728
Holding current value
$50,191
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$2.67 - $3.75 $50,003 - $70,230
18,728 New
18,728 $50,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $224M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Rpo LLC Portfolio

Follow Rpo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rpo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rpo LLC with notifications on news.